| A population-based study of genes previously implicated in breast cancer C Hu, SN Hart, R Gnanaolivu, H Huang, KY Lee, J Na, C Gao, J Lilyquist, ... New England Journal of Medicine 384 (5), 440-451, 2021 | 574 | 2021 |
| A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high … H LaDuca, EC Polley, A Yussuf, L Hoang, S Gutierrez, SN Hart, S Yadav, ... Genetics in Medicine 22 (2), 407-415, 2020 | 180 | 2020 |
| Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century S Yadav, D Karam, I Bin Riaz, H Xie, U Durani, N Duma, KV Giridhar, ... Cancer 126 (1), 26-36, 2020 | 127 | 2020 |
| Sclerosing mesenteritis: a systematic review of 192 cases P Sharma, S Yadav, CM Needham, P Feuerstadt Clinical Journal of Gastroenterology 10 (2), 103-111, 2017 | 109 | 2017 |
| Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants DR Barnes, MA Rookus, L McGuffog, G Leslie, TM Mooij, J Dennis, ... Genetics in Medicine 22 (10), 1653-1666, 2020 | 101 | 2020 |
| Adverse reproductive outcomes associated with teenage pregnancy S Yadav, D Choudhary, KC Narayan, R Mandal, A Sharma, S Chauhan, ... McGill Journal of Medicine 11 (2), 141-144, 2008 | 101 | 2008 |
| Sex differences in tolerability to anti‐programmed cell death protein 1 therapy in patients with metastatic melanoma and non‐small cell lung cancer: are we all equal? N Duma, A Abdel‐Ghani, S Yadav, KP Hoversten, CT Reed, AN Sitek, ... The oncologist 24 (11), e1148-e1155, 2019 | 98 | 2019 |
| Male BRCA mutation carriers: clinical characteristics and cancer spectrum M Ibrahim, S Yadav, F Ogunleye, D Zakalik BMC cancer 18, 1-9, 2018 | 93 | 2018 |
| Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer M Kohli, W Tan, T Zheng, A Wang, C Montesinos, C Wong, P Du, S Jia, ... EBioMedicine 54, 2020 | 86 | 2020 |
| Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer S Yadav, C Hu, SN Hart, N Boddicker, EC Polley, J Na, R Gnanaolivu, ... Journal of Clinical Oncology 38 (13), 1409-1418, 2020 | 83 | 2020 |
| Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis S Yadav, H Xie, I Bin-Riaz, P Sharma, U Durani, G Goyal, B Borah, ... European Journal of Surgical Oncology, 2019 | 81 | 2019 |
| The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort C Hu, EC Polley, S Yadav, J Lilyquist, H Shimelis, J Na, SN Hart, ... JNCI: Journal of the National Cancer Institute 112 (12), 1231-1241, 2020 | 74 | 2020 |
| Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness JH Gertsch, B Corbett, PS Holck, A Mulcahy, M Watts, NT Stillwagon, ... Wilderness & environmental medicine 23 (4), 307-315, 2012 | 74 | 2012 |
| Comparison of accuracy of physical examination findings in initial progress notes between paper charts and a newly implemented electronic health record S Yadav, N Kazanji, N KC, S Paudel, J Falatko, S Shoichet, M Maddens, ... Journal of the American Medical Informatics Association 24 (1), 140-144, 2017 | 68 | 2017 |
| Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy AM Baschnagel, S Yadav, O Marina, A Parzuchowski, TB Lanni Jr, ... Head & neck 36 (8), 1155-1161, 2014 | 68 | 2014 |
| Contribution of germline predisposition gene mutations to breast cancer risk in African American women JR Palmer, EC Polley, C Hu, EM John, C Haiman, SN Hart, M Gaudet, ... JNCI: Journal of the National Cancer Institute 112 (12), 1213-1221, 2020 | 65 | 2020 |
| Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness VL Patel, EL Busch, TM Friebel, A Cronin, G Leslie, L McGuffog, J Adlard, ... Cancer research 80 (3), 624-638, 2020 | 54 | 2020 |
| Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future S Yadav, FJ Couch American Society of Clinical Oncology Educational Book 39, 61-74, 2019 | 54 | 2019 |
| Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer —Association With Patient and Disease Characteristics and Effect on … PA Fasching, S Yadav, C Hu, M Wunderle, L Häberle, SN Hart, M Rübner, ... Journal of Clinical Oncology 39 (15), 1619-1630, 2021 | 52 | 2021 |
| Demographics, tumor characteristics, treatment, and survival of patients with Klatskin tumors P Sharma, S Yadav Annals of gastroenterology 31 (2), 231, 2018 | 50 | 2018 |
Steven HartMayo ClinicVerified email at mayo.edu
